| Market Cap | ₹10,588Cr |
| ROE | 42.11% |
| P/E Ratio(TTM) | 26.72 |
| EPS(TTM) | 172.04 |
| P/B Ratio | 12.30 |
| Dividend Yield | 2.54% |
| Industry P/E | 33.42 |
| Book Value | 373.70 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Parent Organisation | Sanofi India Limited |
| Managing Director | Mr. Rodolfo Hrosz |
| NSE Symbol | SANOFI |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 41.54 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 45.05 | ||
| Pfizer | NA (0.00%) | 29.11 | ||
| Astrazeneca Pharma India | NA (0.00%) | 114.07 |